Insiders who reported open-market trades in the last 12 months at the companies Nancy T. Chang files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Mel Sorensen - $1K in GRTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Nancy T. Chang is a corporate insider, tracked as Director, 10% Owner of Galera Therapeutics, Inc. (GRTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nancy T. Chang submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Nancy T. Chang been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($199K) across all tracked filings.
Nancy T. Chang is Director, 10% Owner of Galera Therapeutics, Inc. (GRTX). 7 SEC Form 4 filings on record going back to 2025, most recently on 5 August 2026. Most recent open-market trade: sold $199K of WTI on 16 July 2026. Lifetime open-market sales: $199K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Nancy T. Chang.
InsiderAlpha's records for Nancy T. Chang go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
